Table 4 Bleeding locations
Total (n = 346) | DOAC (n = 74) | Vitamin K antagonist (n = 272) | p | ||||
|---|---|---|---|---|---|---|---|
Intracranial | 213 | (61.6) | 45 | (60.8) | 168 | (61.8) | 0.881 |
Upper/lower gastrointestinal | 38 | (11.0) | 24 | (18.9) | 14 | (8.8) | 0.014 |
Superficial | 22 | (6.4) | 4 | (5.4) | 18 | (6.6) | 0.705 |
Extremity | 17 | (4.9) | 2 | (2.7) | 15 | (5.5) | 0.321 |
Abdominal | 13 | (3.8) | 2 | (2.7) | 11 | (4.0) | 0.591 |
Thorax | 11 | (3.2) | 4 | (5.4) | 7 | (2.6) | 0.218 |
Eye | 6 | (1.7) | 1 | (1.4) | 5 | (1.8) | 0.776 |
Retroperitoneal | 5 | (1.4) | 1 | (1.4) | 4 | (1.5) | 0.939 |
Haematuria | 3 | (0.9) | 1 | (1.4) | 2 | (0.7) | 0.612 |
Epistaxis | 2 | (0.6) | 0 | (0.0) | 2 | (0.7) | 0.459 |
Oral | 1 | (0.3) | 0 | (0.0) | 1 | (0.4) | 0.601 |